Tocqueville Asset Management L.P. Sells 87,500 Shares of Progyny, Inc. (NASDAQ:PGNY)

Tocqueville Asset Management L.P. decreased its holdings in shares of Progyny, Inc. (NASDAQ:PGNY) by 51.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 84,000 shares of the company’s stock after selling 87,500 shares during the period. Tocqueville Asset Management L.P. owned 0.10% of Progyny worth $1,449,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in PGNY. Victory Capital Management Inc. increased its stake in shares of Progyny by 56.8% during the third quarter. Victory Capital Management Inc. now owns 113,336 shares of the company’s stock valued at $1,900,000 after purchasing an additional 41,035 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Progyny during the third quarter valued at approximately $77,000. King Luther Capital Management Corp increased its position in shares of Progyny by 39.1% during the third quarter. King Luther Capital Management Corp now owns 164,760 shares of the company’s stock valued at $2,761,000 after acquiring an additional 46,281 shares in the last quarter. Aurora Investment Counsel bought a new stake in shares of Progyny during the third quarter valued at approximately $1,280,000. Finally, Intech Investment Management LLC increased its position in shares of Progyny by 282.0% during the third quarter. Intech Investment Management LLC now owns 42,013 shares of the company’s stock valued at $704,000 after acquiring an additional 31,014 shares in the last quarter. Institutional investors own 94.93% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on PGNY shares. JPMorgan Chase & Co. raised their price target on shares of Progyny from $17.00 to $23.00 and gave the company a “neutral” rating in a research report on Tuesday, January 28th. Canaccord Genuity Group raised their price target on shares of Progyny from $17.00 to $23.00 and gave the company a “hold” rating in a research report on Friday, February 28th. Finally, Bank of America raised their price target on shares of Progyny from $21.00 to $25.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, Progyny has an average rating of “Hold” and an average target price of $24.82.

Insider Transactions at Progyny

In other Progyny news, Chairman David J. Schlanger purchased 150,000 shares of the company’s stock in a transaction dated Thursday, December 26th. The shares were acquired at an average price of $14.68 per share, for a total transaction of $2,202,000.00. Following the purchase, the chairman now directly owns 228,269 shares of the company’s stock, valued at $3,350,988.92. The trade was a 191.65 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Peter Anevski acquired 209,500 shares of the firm’s stock in a transaction dated Monday, December 23rd. The shares were purchased at an average price of $14.48 per share, for a total transaction of $3,033,560.00. Following the completion of the transaction, the chief executive officer now directly owns 441,463 shares in the company, valued at approximately $6,392,384.24. This trade represents a 90.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 12.30% of the company’s stock.

Progyny Price Performance

Shares of Progyny stock opened at $21.71 on Thursday. The company’s fifty day simple moving average is $21.80 and its 200-day simple moving average is $18.61. The stock has a market capitalization of $1.85 billion, a PE ratio of 37.43, a P/E/G ratio of 2.39 and a beta of 1.41. Progyny, Inc. has a 1-year low of $13.39 and a 1-year high of $38.98.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.